TP53 and non-small cell lung carcinoma: It is an open question whether in vivothese cells then die from apoptosis or were arrested for a certain time and startregrowing eventually, which is well in accordance with data from a recent study inpatient derived NSCLC xenografts showing a better long-term response to SAG inmodels with mutated TP53 [7].